Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional
Official Title: Inhaled Budesonide for Altitude Illness Prevention
Brief Summary: A randomized, double-blinded study administering budesonide, a medication to reduce inflammation in the lungs, to healthy volunteers to examine effects on altitude illness prevention by spending 18 hours overnight at 14,000 ft elevation.